Microneedle Drug Delivery Systems Market Trends

Growth Drivers 

• Advancements in drug delivery systems: As the utility of products from the microneedle drug delivery systems market rises in various medical disciplines, the surge for more innovative options is increasing. This is influencing companies to incorporate new materials and smart technologies, such as biodegradable regimens, in their pipeline. On the other hand, these commodities are gaining traction for delivering efficiency and safety while maintaining compliance with regulatory standards. Thus, continuous upgrades in products are an indication of greater global penetration and higher revenue generation.
   
• Extended application in biologics delivery: Currently, the technology used in the market is also being utilized for large-scale vaccination. Vaccine reluctance due to fear of needles, pain, and side effects is becoming a serious problem for global health authorities, particularly during pandemics. According to a survey published by NLM, the acceptance rate of COVID-19 vaccines in the U.S. was only 56.9% till April 2020, and the same was 40.0% in Hong Kong till March. This issue can be mitigated by this needle-free vaccine delivery due to its minimally invasive nature, inflating demand in this sector.

Challenges 

• Concerns associated with the system: Drug degradation, poor absorption, and local discomfort are some of the major concerns associated with the products from the market. Both coated and hollow microneedles possess the risk that the drug may not properly enter the skin and may not be effective. Some of the material used to construct these systems cannot be absorbed by the body, and any fragments of them may create irritation, resulting in consumer dissatisfaction and limitation in wide adoption.